Morgane Van Wettere Selected Research

Budd-Chiari Syndrome (Budd Chiari Syndrome)

6/2020	Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.
1/2018	Benign and malignant hepatocellular lesions in patients with vascular liver diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Morgane Van Wettere Research Topics

Disease

2	Budd-Chiari Syndrome (Budd Chiari Syndrome) 06/2020 - 01/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 06/2020
1	Intracranial Aneurysm (Cerebral Aneurysm) 12/2018
1	Aneurysm (Aneurysms) 12/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Hereditary Hemorrhagic Telangiectasia 01/2018
1	Abdominal Pain (Pain, Abdominal) 04/2014
1	Cystic Fibrosis (Mucoviscidosis) 04/2014

Drug/Important Bio-Agent (IBA)

1	Cytidine Triphosphate (CTP)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Contrast MediaIBA 06/2020
1	MetalsIBA 12/2018

Therapy/Procedure

1	Surgical Instruments (Clip) 12/2018
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2018
1	Appendectomy 04/2014